AHBARx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: buyers who want a no-commitment monthly supply and a published phone line
AHBARx scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Not disclosed
Provider visits
Not disclosed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
AHBARx is a Newport Beach telehealth storefront selling compounded semaglutide and tirzepatide alongside NAD+, sermorelin, glutathione and B12 injections. GLP-1 pricing is published as straightforward supply bundles: semaglutide is $249 for one month, $649 for three and $1,199 for six, with tirzepatide at $349, $949 and $1,799. Every advertised bundle saving reconciles against the one-month rate.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to AHBARx
Editorial score · methodology
TMates
Best for: nationwide compounded GLP-1 availability including Puerto Rico
Editorial score · methodology
Editorial score · methodology
AHBARx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $200/mo
- FDA status
- No FDA warning letter on record
How we scored AHBARx
Each dimension is scored algorithmically from AHBARx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.3/10At $200/mo, AHBARx runs about 18% above the $169 median for GLP-1 providers.
Effectiveness25%
7.8/10AHBARx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.9/10Online intake and platform experience; 7 platform features disclosed.
Trust & Safety15%
6.7/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-27).
Accessibility10%
8.0/10AHBARx treats patients in all 50 states.
Support10%
5.6/10AHBARx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this AHBARx review
Last checked August 2026- Confirmed current pricing across 6 dose/plan tiers
- Confirmed availability in all 50 states
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with AHBARx
We walked AHBARx’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse to the semaglutide or tirzepatide page from the Weight Loss or All Treatments menu.
- 2All three supply tiers, their prices and their delivery cadences are listed before any intake.
- 3Select "Add to Cart" on a tier — the cart counter increments in the header.
- 4The walk stopped there: the cart is a client-side drawer and /cart/ returns a not-found page, so no checkout terms could be read.
- Pricing is published without an account and each tier names its own cadence — "Delivered monthly", "Every 3 Months Delivery", "Charged every 6 months".
- The 6-month tier is explicit that billing and delivery differ: charged every six months, "Medication delivered every 3 months".
- Both drugs' savings figures reconcile exactly ($249 x 3 - $649 = $98; $249 x 6 - $1,199 = $295), which is not the norm among peers checked the same day.
- The terms and conditions are visibly an unfilled template, leaving pharmacies, labs and medical groups unnamed.
- A patient-portal mockup on the homepage advertises "Cancel anytime" and "No membership fees".
- Checkout could not be reached without an account, so the renewal and refund mechanics remain unconfirmed.
AHBARx customer support
- Phone
- 909-999-2422
- hello@ahbarx.com
GLP-1 medications AHBARx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check AHBARx's current pricing and active discounts before you decide.
What we like
- Prices are on the product page with no login, and each tier states its own delivery cadence.
- Every advertised bundle saving is arithmetically correct against the one-month rate for both drugs.
- A true one-month supply is offered at $249 for semaglutide, so no long commitment is required to start.
- The site states there are no membership fees and that patients can cancel at any time.
- Each refill is described as reviewed at a follow-up consultation rather than shipped automatically without review.
- A staffed phone line is published at 909-999-2422 alongside hello@ahbarx.com.
Watch-outs
- No legal entity is named anywhere — the terms and privacy policy refer only to "AHBARx and/or its subsidiaries and affiliates".
- The terms are an unfilled template — pharmacies, labs and medical groups appear as literal "[list of Pharmacies]" placeholders.
- Even the site's own domain is left as a bracketed placeholder, "[www.ahbarx.com]", in both the terms and the privacy policy.
- The footer claims "LegitScript certified" but no certification record could be retrieved to confirm it.
- The 6-month bundle is charged upfront for six months while medication ships only every three.
- State coverage is a blanket "all 50 states" claim with no list published.
- The checkout could not be reached to confirm renewal terms — the cart is a script drawer with no reachable page.
Is AHBARx worth it? Our verdict
AHBARx positions itself around one thing: buyers who want a no-commitment monthly supply and a published phone line. It runs $200/month — a premium to the category, so the extras need to justify it. It treats patients in all 50 states, so access isn't a barrier.
On top of the prescription itself, AHBARx points to NAD+, Sermorelin, and No Membership Fee.
How much AHBARx actually costs
- Compounded semaglutide — $249/month
- Compounded semaglutide — $216/month
- Compounded semaglutide — $200/month
- Compounded tirzepatide — $349/month
- Compounded tirzepatide — $316/month
- Compounded tirzepatide — $300/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so AHBARx's standing rate sits at the premium end.
For a direct comparison, Breeze Meds runs semaglutide and tirzepatide from $199/month — worth pricing against AHBARx before you commit.
Medications: what AHBARx prescribes
AHBARx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who AHBARx is best for — and who should skip it
A good fit if you…
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Sunlight will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
AHBARx treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
AHBARx costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Oak is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
AHBARx scores highest on state availability and ease of access.
Ready to start with AHBARx?
Starting at $200/month. See current pricing and start your free consultation.
AHBARx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this AHBARx review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See AHBARx's current pricing
Plans start at $200/month. Start your free consultation to check eligibility and today's price.